Rinoberen en es it fr

Rinoberen Brand names, Rinoberen Analogs

Rinoberen Brand Names Mixture

  • Combivent Inhalation Aerosol (Ipratropium Bromide + Salbutamol Sulfate)
  • Combivent Inhalation Solution (Ipratropium Bromide + Salbutamol Sulfate)
  • Duovent Udv (Fenoterol Hydrobromide + Ipratropium Bromide)
  • Ratio-Ipra Sal Udv (Ipratropium Bromide + Salbutamol Sulfate)

Rinoberen Chemical_Formula


Rinoberen RX_link


Rinoberen fda sheet

Rinoberen FDA

Rinoberen msds (material safety sheet)

Rinoberen Synthesis Reference

K. Zeile et al.,U.S. Pat. 3,505,337 (1970)

Rinoberen Molecular Weight

332.457 g/mol

Rinoberen Melting Point


Rinoberen H2O Solubility

Freely soluble

Rinoberen State


Rinoberen LogP

No information avaliable

Rinoberen Dosage Forms

Aerosol (with propellants); Liquid; Metered-dose (aerosol); Metered-dose (pump); Solution

Rinoberen Indication

For maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Rinoberen Pharmacology

Ipratropium bromide, a synthetic ammonium compound structurally similar to atropine, is used as a bronchodilator in the management of cholinergic-mediated bronchospasm associated with chronic obstructive pulmonary disease and in the treatment of rhinorrhea associated with the common cold or with allergic or nonallergic seasonal rhinitis.

Rinoberen Absorption

Inhalation (local)-minimal; Nasal-rapid and minimal

Rinoberen side effects and Toxicity

LD50=1001mg/kg (orally in mice)

Rinoberen Patient Information

Rinoberen Organisms Affected

Humans and other mammals